CCND1 and head and neck squamous cell carcinoma: Using a previously established syngenic 11q13 amplified HNSCC cell line model of primary cisplatin (CDDP) resistance, we thus investigated in detail the role of CCND1 and ANO1 amplification in treatment resistance.